<?xml version='1.0' encoding='UTF-8'?>
<extracted-tables-set><pmcid/><all-ids><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="pmcid">PMC6296345</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="pmcid-ver">PMC6296345.1</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="pmcaid">6296345</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="pmcaiid">6296345</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="pmid">30531675</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="doi">10.12659/MSM.912153</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="publisher-id">912153</article-id></all-ids><extracted-table><table-id>t1-medscimonit-24-8910</table-id><table-label>Table 1</table-label><table-caption>A summary of the multimodal MRI to assess leukoaraiosis with cognitive impairment.</table-caption><table-wrap-foot/><original-table><table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" id="t1-medscimonit-24-8910" position="float" orientation="portrait"><label>Table 1</label><caption><p>A summary of the multimodal MRI to assess leukoaraiosis with cognitive impairment.</p></caption><table frame="hsides" rules="rows"><thead><tr><th valign="middle" align="center" rowspan="1" colspan="1"/><th valign="middle" align="center" rowspan="1" colspan="1">Multimodal MRI techniques</th><th valign="middle" align="center" rowspan="1" colspan="1">Main observation targets</th><th valign="middle" align="center" rowspan="1" colspan="1">The main findings</th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">1</td><td valign="top" align="left" rowspan="1" colspan="1">Structural Magnetic Resonance Imaging (sMRI)</td><td valign="top" align="left" rowspan="1" colspan="1">Gray-matter atrophy, white-matter lesions, and whole-brain atrophy</td><td valign="top" align="left" rowspan="1" colspan="1">Decreased gray-matter density in frontal lobes, hippocampus, and cingulate cortex;<break/>lower cortical thickness in multimodal integration regions, such as frontotemporal regions</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">2</td><td valign="top" align="left" rowspan="1" colspan="1">Blood oxygen level-dependent (BOLD) contrast</td><td valign="top" align="left" rowspan="1" colspan="1">Identify the intrinsic spontaneous brain neural activity during resting state to investigate the brain function, such as amplitude of low-frequency fluctuations (ALFF) and default-mode network (DMN)</td><td valign="top" align="left" rowspan="1" colspan="1">Significant decrease in ALFF in the left parahippocampal gyrus (PHG) and an increased ALFF in right superior orbital frontal gyrus (SOFG);<break/>increased functional connectivity (FC) between the right insular region and the right SOFG and between the right calcarine cortex and the left PHG;<break/>significant differences in functional alterations of the DMN</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">3</td><td valign="top" align="left" rowspan="1" colspan="1">Cerebrovascular reactivity (CVR) measurements</td><td valign="top" align="left" rowspan="1" colspan="1">Cerebral autoregulation and vasodilatory capacity</td><td valign="top" align="left" rowspan="1" colspan="1">Impaired CVR may contribute to the progression of white matter disease</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">4</td><td valign="top" align="left" rowspan="1" colspan="1">Diffusion tensor imaging (DTI)</td><td valign="top" align="left" rowspan="1" colspan="1">Determine the integrity and lesions of white-matter tracts, such as fractional anisotropy (FA) and mean diffusivity (MD)</td><td valign="top" align="left" rowspan="1" colspan="1">Dysfunction of white matter integrity;<break/>DTI parameters (especially FA) could serve as a potent imaging indicator for detecting the invisible alteration of white matter integrity</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">5</td><td valign="top" align="left" rowspan="1" colspan="1">Dynamic contrast enhancement (DCE) MRI</td><td valign="top" align="left" rowspan="1" colspan="1">Evaluate the permeability and integrity of blood-brain barrier (BBB); quantitative tissue perfusion such as blood volume, mean transit time, mean transit time</td><td valign="top" align="left" rowspan="1" colspan="1">Higher BBB permeability was associated with higher LA burden and cognitive decline</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">6</td><td valign="top" align="left" rowspan="1" colspan="1">Magnetic resonance spectroscopy (MRS)</td><td valign="top" align="left" rowspan="1" colspan="1">Identify changes in cerebral metabolites such as the ratios of N-acetyl aspartate (NAA)/choline (Cho) and NAA/creatine (Cr)</td><td valign="top" align="left" rowspan="1" colspan="1">Metabolic changes suggested that MRS can be explored as a marker for cognitive dysfunction in patients with LA</td></tr></tbody></table></table-wrap></original-table><transformed-table>Table 1<div xmlns="http://www.w3.org/1999/xhtml" class="caption">A summary of the multimodal MRI to assess leukoaraiosis with cognitive impairment.</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="rows"><thead><tr><th valign="middle" align="center"/><th valign="middle" align="center">Multimodal MRI techniques</th><th valign="middle" align="center">Main observation targets</th><th valign="middle" align="center">The main findings</th></tr></thead><tbody><tr><td valign="top" align="left">1</td><td valign="top" align="left">Structural Magnetic Resonance Imaging (sMRI)</td><td valign="top" align="left">Gray-matter atrophy, white-matter lesions, and whole-brain atrophy</td><td valign="top" align="left">Decreased gray-matter density in frontal lobes, hippocampus, and cingulate cortex;lower cortical thickness in multimodal integration regions, such as frontotemporal regions</td></tr><tr><td valign="top" align="left">2</td><td valign="top" align="left">Blood oxygen level-dependent (BOLD) contrast</td><td valign="top" align="left">Identify the intrinsic spontaneous brain neural activity during resting state to investigate the brain function, such as amplitude of low-frequency fluctuations (ALFF) and default-mode network (DMN)</td><td valign="top" align="left">Significant decrease in ALFF in the left parahippocampal gyrus (PHG) and an increased ALFF in right superior orbital frontal gyrus (SOFG);increased functional connectivity (FC) between the right insular region and the right SOFG and between the right calcarine cortex and the left PHG;significant differences in functional alterations of the DMN</td></tr><tr><td valign="top" align="left">3</td><td valign="top" align="left">Cerebrovascular reactivity (CVR) measurements</td><td valign="top" align="left">Cerebral autoregulation and vasodilatory capacity</td><td valign="top" align="left">Impaired CVR may contribute to the progression of white matter disease</td></tr><tr><td valign="top" align="left">4</td><td valign="top" align="left">Diffusion tensor imaging (DTI)</td><td valign="top" align="left">Determine the integrity and lesions of white-matter tracts, such as fractional anisotropy (FA) and mean diffusivity (MD)</td><td valign="top" align="left">Dysfunction of white matter integrity;DTI parameters (especially FA) could serve as a potent imaging indicator for detecting the invisible alteration of white matter integrity</td></tr><tr><td valign="top" align="left">5</td><td valign="top" align="left">Dynamic contrast enhancement (DCE) MRI</td><td valign="top" align="left">Evaluate the permeability and integrity of blood-brain barrier (BBB); quantitative tissue perfusion such as blood volume, mean transit time, mean transit time</td><td valign="top" align="left">Higher BBB permeability was associated with higher LA burden and cognitive decline</td></tr><tr><td valign="top" align="left">6</td><td valign="top" align="left">Magnetic resonance spectroscopy (MRS)</td><td valign="top" align="left">Identify changes in cerebral metabolites such as the ratios of N-acetyl aspartate (NAA)/choline (Cho) and NAA/creatine (Cr)</td><td valign="top" align="left">Metabolic changes suggested that MRS can be explored as a marker for cognitive dysfunction in patients with LA</td></tr></tbody></table></div></transformed-table></extracted-table></extracted-tables-set>